...
机译:LNCRNA Miat介导的DLG3启动子甲基化的沉默抑制DLG3启动子甲基化通过河马信号通路抑制乳腺癌进展
Zhejiang Univ Dept Oncol Affiliated Hosp 4 Sch Med N1 Shangcheng Rd Yiwu 322000 Zhejiang Peoples R China;
Cent South Univ Dept Oncol Xiangya Hosp 2 Changsha 410011 Peoples R China;
Nanchong Cent Hosp Dept Oncol North Sichuan Med Coll Nanchong 637000 Peoples R China;
North Sichuan Med Coll Sch Basic Med Dept Anat Nanchong 637000 Peoples R China;
Nanchong Cent Hosp Dept Oncol North Sichuan Med Coll Nanchong 637000 Peoples R China;
Nanchong Cent Hosp Dept Oncol North Sichuan Med Coll Nanchong 637000 Peoples R China;
Nanchong Cent Hosp Dept Oncol North Sichuan Med Coll Nanchong 637000 Peoples R China;
Nanchong Cent Hosp Dept Oncol North Sichuan Med Coll Nanchong 637000 Peoples R China;
LncRNA MIAT; DLG3; Hippo signaling pathway; Breast cancer; Epithelial-to-mesenchymal transition; Lymph node metastasis;
机译:LNCRNA Miat介导的DLG3启动子甲基化的沉默抑制DLG3启动子甲基化通过河马信号通路抑制乳腺癌进展
机译:LNCRNA LINC00857通过调制河马信号通路来调节卵巢癌中的进展和糖酵解
机译:LNCRNA ANCR通过抑制Wnt /β-catenin信号传导途径来抑制肝细胞癌的进展
机译:甲基化抑制对人乳腺癌细胞细胞增殖和转移的影响
机译:在乳腺癌1(DBC1)中删除,通过负调控替代NFkappaB信号通路抑制B细胞激活。
机译:癌症进展中的LNCRNA和河马信号通路之间的串扰
机译:> LNCRNA ANCR通过抑制WNT /β-catenin信号传导途径的抑制肝细胞癌的进展 p>
机译:BRms1通过调节microRNa-125b和TNF-α和HER2信号通路的下游衰减抑制乳腺癌向骨转移